top of page

Paving the way to efficient and sustainable future of adherent cell cultivation -
for people
and the planet.

_XXX7849.JPG
Krankenhaus
affected by rare diseases globally.¹

Healthy People: Enabling 
patient access

 

New therapies become approved in a fast-paced manner, but how accessible are these to patients?

Cell and gene therapy (CGT) costs up to $4.25 m per dose.⁵ A price tag that most patients are not able to cover themselves or to be paid by their health insurances. Advanced therapies are therefore not accessible for everyone.

In cell & gene therapy, manual labor causes up to 71% of production costs.⁶ Manufacturing therapies includes a complex and intensive cell cultivation process.

Innovating scalable systems for adherent cell culture, like the CellScrew®, are key to increasing patient access and affordability to life-changing novel therapies. 

Healthy planet: Cutting carbon emissions

Healthy people need a healthy planet. Aiming to help people and treat diseases, the healthcare sector produces 55% more greenhouse gas (GHG) emissions than the automotive industry.⁷

The industry produces massive amounts of plastic waste and accounts for 4.4% of the global net carbon emissions, harming the environment we live in and rely on. More than ever before, it is obvious that limiting temperature rise by reducing emissions is essential for preventing further damage to the health of our planet and ourselves.

How can we reduce the impact of our healthcare system?

 

Being the pioneering company for the production of labware from plant-based plastic, we empower the biopharmaceutical industry to embrace sustainability.

are caused by the healthcare sector.⁸

About Green Elephant Biotech

Green Elephant Biotech was founded in 2021 by Dr. Joel Eichmann and Felix Wollenhaupt. Since then, our team has grown to include diverse team members with expertise in bioprocessing, business development, and marketing. We're a passionate and diverse team of highly motivated young professionals, driven to build a sustainable future by revolutionizing the biotech and pharma industry.

The Green Elephant team walks towards the camera

Our locations

Gießen
Kerkrader Straße 9

PB230389.JPG

Giessen is where it all began for us. Here, our R&D team works on developing new sustainable products, and our Quality Management team ensures compliance with the relevant regulations.
Our flagship product, the CellScrew®, is manufactured on-site in our production facilities.

Berlin
Prenzlauer Allee 36 G

_XXX8810.JPG

Our Berlin office manages the business operations. The Sales and Marketing team promote the company and our sustainable products. We maintain close communication with customers, business partners, and our R&D team.

Impact
leaf_texture_01_edited_edited.jpg

Our contribution to the Sustainable Development Goals

SDG 3 Good Health and Well-Being

A seamless pipeline from biopharma research and development to manufacturing is crucial in delivering life-saving treatments to patients cost-effectively and within a short time-to-market.

 

Our CellScrew® product is built on the idea of empowering the biopharmaceutical industry to operate more sustainably and efficiently. With our innovative solutions, we aim to overcome the challenge of limited production capacity in the biopharmaceutical sector by introducing an easily adoptable cell culture system that maximizes productivity.

You might know us from ...

Logo Founders League
Logo Laborjournal
Logo Frankfurter Rundschau

Company Updates

We are
supported by ...

BSFZ_Siegel
Logo Invest - Zuschuss für Wagniskapital
Logo 5HT Digital Hub Chemistry Health
Logo Bio Deutschland

And awarded
with ...

Logo Innovationspreis der Region Göttingen
Logo Science4Life
Icon 2nd Prize Biopolymer Innovation Award
Logo Hessischer Gründerpreis HGP

Green Elephant Biotech is a spin-off of the University of Applied Science Mittelhessen in Giessen, Germany.

Logo Technische Hochschule Mittelhessen (THM)

Do you have questions or a request? We look forward to your message. 

bottom of page